Tagrisso 80 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FYSLA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,304
Award facts
- Contract value 100% obligated
- $21,303.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,303.64 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 MG tablets (30-count units) under a firm fixed-price contract. This non-set-aside award was issued on September 29, 2025, with an ultimate completion date of October 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery order. The contract is a child order issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor and critical vendor within the federal medical procurement system, supplying a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. This delivery order for TAGRISSO, an oncology medication, reflects the company's ongoing role in fulfilling pharmaceutical needs across the Defense Health Agency and other federal healthcare customers. The company's capacity to deliver through open competitive procurement, combined with its prime vendor status under the DLA's pharmaceutical support network, positions it as a key supplier for the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FYSLA?
SPE2DB25FYSLA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FYSLA worth?
The government has obligated $21,304 on SPE2DB25FYSLA.
Is contract SPE2DB25FYSLA an order under another contract?
Yes. SPE2DB25FYSLA is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYSLA competed?
The extent of competition for SPE2DB25FYSLA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award